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ABSTRACT
INTRODUCTION: Melanoma is a malignant tumor with an unfavorable prognosis and an increasing inci-
dence worldwide, with the most significant and the most common type being cutaneous melanoma. The ep-
idemiological characteristics of cutaneous melanoma in Bulgaria are presented with low morbidity, moder-
ate growth rate, and relatively low mortality, but with a rapid rate of increase in both sexes.
AIM: The aim of this study was to establish the clinical and morphological features of cutaneous melanoma 
in the Dobrich district and compare them to the European trends.
MATERIALS AND METHODS: A retrospective non-clinical approach was used in the selection of patients. 
The study included patients with histologically proven skin melanoma in the period 2016–2019. Data on pa-
tient sex, age at diagnosis, tumor location, and clinical stage of the disease were collected according to Clark 
and Breslow criteria.
RESULTS: The collected data show that the cutaneous melanoma in Dobrich district has a profile different 
from the average European one—all age groups are affected, except for 11- to 20-year-olds, and most cases 
occur in the age group of 61- to 70-year-olds, with an average age of diagnosis 59.82 years. In regard to sex 
distribution, men are more common, and the most common localization is the lower limbs. Morphological 
features show an advanced nature of the disease with a diagnosis in the late clinical stages.
CONCLUSION: Our data show that the gender distribution of cases corresponds to the European average, 
but the age and clinical stage of the disease are significantly more advanced, indicating a delayed diagnosis 
and emphasizing the need to develop a campaign for the prevention and early diagnosis.
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Melanoma is a malignant tumor of melano-
cytic origin, unfavorable prognosis, and increas-
ing frequency worldwide (1). The most significant 
and most frequent type of melanoma is cutaneous 
melanoma (2). It is a relatively rare malignancy, but 
it is the most common cause of death from malig-
nant skin tumors, with increasing mortality. Howev-
er, the mortality rate in Europe is relatively low and 
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Statistical Data Processing
The collected data was analyzed and graphical-
ly represented using the built-in features of Micro-
soft Office 365 (Microsoft Corporation, Redmond, 
Washington, United States).
RESULTS
The study cohort included a total of 28 patients 
who met the set criteria, of which 57.14% (n=16) were 
male and 42.86% (n=12) female (Fig. 1A). Cases were 
observed in all age groups, except for 11- to 20-year-
olds, with the highest incidence being observed in 
the age group of 61 to 70 years, followed by these of 
71 to 80 years and 51 to 60 years (Fig. 1B).
Clinical data on tumor location were avail-
able for 24 out of the 28 patients, with 25% of cases 
(n=6) being located on the lower limbs, followed by 
the back and chest with 20.83% of cases (n=5) each 
(Fig. 2).
Morphological examination of the excised tu-
mor tissue showed that the majority of patients, re-
gardless of gender and age, had tumors with ad-
vanced Clark and Breslow stages (Fig. 3), corre-
sponding to a long period from their origin to the 
medical intervention.
DISCUSSION
According to the National Cancer Registry in 
the collections “Cancer Incidence in Bulgaria” for 
the previous four years—2012 to 2015, a total of 47 
cases of cutaneous melanoma were diagnosed in Do-
brich, with an annual incidence ranging between 7 
and 16 cases per year and gender-age distribution 
shows a trend of stabilization and reduction, mainly 
in Northwestern Europe (2–4). Mortality in Eastern 
Europe is the highest across the continent, however, 
it shows a trend of increased survival.
Cutaneous melanoma in Bulgaria presents with 
low morbidity, a moderate increase in incidence, rel-
atively low mortality in men, and a medium-high 
one in women, but with a relatively rapid rate of in-
crease in both sexes (2,5–8).
The study of the features and trends in the prev-
alence of melanoma in the Bulgarian population, es-
pecially the demographic and morphological as-
pects of the disease, can provide a map to identify 
risk groups and lead to early diagnosis of cutaneous 
melanoma.
AIM
The aim of this study was to establish the clini-
cal and morphological features of cutaneous melano-




All aspects of the study were carried out accord-
ing to the ethical standards of the Declaration of Hel-
sinki from 1975 and its seventh revision from 2013, 
the ethical norms and regulations of the Ministry of 
Education and Science, and the Ministry of Health 
of the Republic of Bulgaria. The protocol for approv-
al by the Ethics Committee of the Medical University 
of Varna was as follows: №91/27.02.2020.
Financing
Part of the materials for this research were pro-
vided by project 19005/20 of the Science Fund at the 
Medical University of Varna.
Selection of Patients
A retrospective non-clinical approach was 
used in the selection of patients. The study includ-
ed patients with histologically proven skin melano-
ma, initially diagnosed in Diagnostic and Consulta-
tive Center 2 Ltd., Dobrich, in the period 2016–2019. 
Data regarding the gender of patients, age at diagno-
sis, tumor location, and clinical stage of the disease 
(Clark and Breslow) were collected from the central 
database.
Fig. 1. Demographic characteristics of malignant 
melanoma—sex distribution (A) and age group 
distribution (B)
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corresponding to ours (9–11). Data on the incidence 
after 2015 have not yet been published but, based on 
the previous years and the corresponding age and 
gender distribution, most cases of melanoma in Do-
brich district are included in our sample and make it 
representative.
According to Kobakova, the incidence of malig-
nant melanoma in Bulgaria has increased at a mod-
erate rate to 3.8 per 100,000 capita for males and 3.3 
per 100,000 capita for females (12). This would char-
acterize the annual incidence in Dobrich district of 
3.26 cases for males and 2.98 for females by a trend 
of negative annual population growth of over 7 per 
thousand (13). As can be seen from the data of the 
National Cancer Registry and our statistics, howev-
er, the cases are significantly higher than the average 
morbidity for the country (9–11). Calculated by sta-
tistical means, the newly diagnosed cases should be 
6 annually, with the registered ones being between 7 
and 16 (12).
Probably one of the reasons for the higher inci-
dence, when compared to the national average of cu-
taneous melanoma in the Dobrich region, is related 
to the agricultural nature of the livelihood of a large 
part of the population increasing the exposure to the 
main risk factor—UV radiation (14).
Our data show that malignant melanoma, as a 
nosological unit, is diagnosed in all age groups, apart 
from the age group of 11- to 20-year-olds in which no 
patients were registered. The most common location 
for the development of the disease is the lower limb. 
According to Chernev and Chokoeva, this location is 
associated with better prognosis when compared to 
the trunk, head, and neck areas (15).
Worthy of note is the fact that the disease is ad-
vanced, at an advanced clinical stage at the time of 
diagnosis, which limits the therapeutic response and 
inevitably reduces the survival rate for a disease with 
pronounced metastatic potential, including decades 
after removal of the primary lesion (16).
Bearing in mind the aforementioned data, it is 
necessary to develop a unified national system for 
prevention and early diagnosis, which includes der-
matologists, surgeons, pathologists, and oncologists 
(15, 17). Informing the population about the main 
risk factors, especially in an agricultural region, is 
key to limiting exposure and seeking medical help 
in the early stages of the disease. This would improve 
survival and bring it in line with European trends, as 
well as inevitably increase the number of newly diag-
nosed cases in an earlier clinical phase, given the dis-
covery of hidden cases for current statistics (2).
Additional evidence for the delayed diagnosis is 
evident from the data on gender distribution, which 
corresponds to the average European norms, whilst 
the age trend is lagging behind the European ones.
Study Limitations
The present study, although representative as 
per percentage of the total cases according to the na-
Fig. 2. Distribution of malignant melanoma by location
Fig. 3. Morphological characteristics of malignant 
melanoma according to the Clark scale (A) and the 
Breslow scale (B)
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tional databases of the previous years, does not pres-
ent a complete analysis of all cases in the region. Fur-
ther regional studies are required in all regions of the 
country to properly determine the incidence rates 
and underline the need for prevention programs in 
high-risk areas.
CONCLUSION
Malignant cutaneous melanoma is an aggres-
sive malignancy with a poor clinical prognosis in 
its late clinical stages. Our data show that in the Do-
brich district the gender distribution of cases corre-
sponds to the European average, with the lower limb 
being the leading location of origin, but the age and 
clinical stage of the disease are significantly more ad-
vanced, indicating late diagnosis and emphasizing 
the need to develop a campaign for prevention and 
early diagnosis.
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